drugset / Trial / NCT01359930

Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study

NCT01359930

Phase 1 Completed 16 enrolled National Institute on Drug Abuse (NIDA)
RandomizedParallel-groupTriple-blindDiagnostic

Summary

The study is to primarily measure safety and interactions between oral doses of Naltrexone/Bupropion and i.v. Methamphetamine.

Timeline

Start
2011-08
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupropion Small molecule 200 mg Oral
Comparator Naltrexone Small molecule 25 mg Oral